Overview
Ferroptosis is an iron-dependent form of programmed cell death characterized by lipid peroxidation, implicated in various diseases including neurodegenerative disorders, organ ischemia-reperfusion injury, and inflammatory conditions 1. Novel scaffolds like 2-amino-6-methylphenol derivatives have shown potent anti-ferroptotic activities, offering potential therapeutic avenues 1.Diagnosis
Identification of lipid peroxidation markers (e.g., malondialdehyde) in affected tissues 1.
Assessment of iron metabolism and glutathione levels, as dysregulation is central to ferroptosis 2.
Use of ferroptosis inducers (e.g., erastin, RSL3) to induce and confirm ferroptotic cell death in experimental models 12.Management
First-line treatments: Development and exploration of ferroptosis inhibitors such as 2-amino-6-methylphenol derivatives, targeting lipid peroxidation pathways 1.
Adjunctive therapies: Enhancing glutathione synthesis or iron metabolism regulation through pharmacological agents, guided by transcriptional factors like BACH1 2.Special Populations
Pregnancy: Limited data; further research needed to assess safety and efficacy of ferroptosis inhibitors 12.
Pediatrics: Specific dosing and safety profiles for pediatric use remain unexplored 12.
Elderly: Considerations for altered iron metabolism and oxidative stress responses may necessitate tailored approaches 2.
Comorbidities: Interactions with existing conditions involving oxidative stress and iron metabolism require careful monitoring 2.Key Recommendations
Investigate and utilize novel ferroptosis inhibitors like 2-amino-6-methylphenol derivatives for therapeutic benefit in relevant diseases (Evidence: Moderate 1).
Monitor and modulate glutathione and labile iron metabolism pathways under the influence of transcription factors such as BACH1 to manage ferroptosis (Evidence: Moderate 2).
Conduct further clinical trials to establish safety and efficacy profiles of ferroptosis inhibitors in special populations including pregnant women, children, and the elderly (Evidence: Expert opinion 12).References
1 Sheng XH, Han LC, Ma XJ, Gong A, Hao MZ, Zhu H et al.. Design, synthesis, and biological evaluation of 2-amino-6-methyl-phenol derivatives targeting lipid peroxidation with potent anti-ferroptotic activities. European journal of medicinal chemistry 2024. link
2 Nishizawa H, Matsumoto M, Shindo T, Saigusa D, Kato H, Suzuki K et al.. Ferroptosis is controlled by the coordinated transcriptional regulation of glutathione and labile iron metabolism by the transcription factor BACH1. The Journal of biological chemistry 2020. link